THE IMPORTANCE of tumour markers for the detection of malignancies, and for determining the extent and the clinical course of the disease, has prompted much investigation into the establishment of possible biochemical markers for breast cancer. Although tumour-associated products such as the carcinoembryonic antigen (Wang et al., 1975; Tormey et al., J1977; Cove et al., 1979) and chorionic gonadotropin (Tormey et al., 1976) among others have been suggested as possible candidates, no specific markers have been found for breast cancer. There is considerable evidence that neoplastic transformation is accompanied by a variety of alterations at the cell surface, particularly in the glycoprotein components (see Hynes, 1979; Sherbet, 1978 for review) . Recent work has indicated that a common marker for neoplastic transformation might exist (Price & Stoddart, 1976; Bramwell & Harris, 1978; Bowen & Kulatilake, 1979) . The establishment of a marker associated with malignant behaviour of tumours (i.e. their ability to invade and form distant metastatic deposits) may be of even greater importance, not only in the understanding of the biology of the tumour but also in the clinical management of patients. Diferences in metastatic ability of experimental tumours have recently been shown to be accompanied by changes in the surface components (Brunson et al., 1978;  Accepted 29 September 1990 Yogeeswaran et al., 1978; Turner et al., 1981 (Hynes, 1973) . To each culture flask 2 ml of PBS containing 5mM glucose was added. Carrier-free Na125J
(Radiochemical Centre, Amersham) and glucose oxidase (Boehringer) and lactoperoxidase (Calbiochem) were used at 1 mCi, 2-5 ,g and 1 iu respectively per flask. The constituents were mixed gently and the flasks were left at room temperature for 10 min, with occasional gentle shaking. The reaction was terminated by the addition of 5 ml of phosphate-buffered iodine (PBI) containing 0-137M Nal and 2mM phenyl methyl sulphonyl fluoride (PMSF) (proteinase inhibitor). The iodinated monolayer was washed x 3 in PBI-PMSF solution. The cells were scraped off with a polypropylene "policeman" and solubilized in 0-3 ml of 001M sodium phosphate buffer (pH 7.0) containing 1% (w/v) sodium dodecyl sulphate, 1% (w/v) The + sign indicates the presence of a well-defined peak of radlioiodine incorporation.
233K component occurred as a defined peak in 3/5 carcinomas (Table I) but the difference in radioactive incorporation between fibroadenomas and the carcinoma group was not statistically significant. In Table II the ratios of incorporation of radioiodine with the 265K and 233K components are given. These ratios are higher in the fibroadenoma group than in the carcinoma group. A statistical analysis using the non-parametric statistical technique of Mann and Whitney described by Campbell (1967) revealed that the ratios of the fibroadenoma group differed stochastically from those of the carcinomas (P-0-016). It may be concluded, therefore, that the 265K peak was less in the carcinomas than the fibroadenomas. A third feature which seemed to distinguish between the benign conditions and the carcinomas was the incorporation of the label into components of average mol. wt 63 K. The proportion of radioactivity associated with the 63K components was found to be higher in the carcinomas than in the fibroadenomas (Table II) . This difference also was statistically significant (P < 0.03) in the Mann-Whitney test. Minor differences were found in the proportion of radioactivity associated with the 145K protein, carcinomas as well as in the non-malignant conditions. To summarize, the experiments described here indicate a reduced expression of the 265K and an increased expression of the 63K component on the surface of cells from carcinomas. It is suggested that these changes could be an indicator of the malignancy of the carcinomas. Further work designed to characterize these components is in progress. 
